XM does not provide services to residents of the United States of America.
D
D

Drax

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

JPM sees growth for UK utilities with investment boost, regulatory clarity

BUZZ-JPM sees growth for UK utilities with investment boost, regulatory clarity ** Shares in UK utilities .FTUB6510 up 0.5% at 727.3 pence vs FTSE 100 index .FTSE which is flat at 0.03% ** J.P. Morgan predicts continued growth for UK utilities with increase in investment and regulatory clarity ** Predicts rise in National Grid's NG.L and SSE's SSE.
C
D
P
S
N
S
U
U

Labour win spells more regulatory clarity for UK utilities, JPM says

Labour win spells more regulatory clarity for UK utilities, JPM says July 5 (Reuters) - British utilities are expected to benefit from an increase in investment and regulatory clarity after the centre-left Labour Party's victory in the parliamentary election, analysts at JP Morgan said on Friday. The FTSE utilities index .FTUB6510 was up 0.6% by 0921 GMT, with gains led by British Gas owner Centrica CNA.L and power plant operator Drax DRX.L .
C
D
P
S
U

ASMI, EasyJet, Kooth

EUROPE RESEARCH ROUNDUP-ASMI, EasyJet, Kooth July 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ASMI, EasyJet and Kooth, on Wednesday. HIGHLIGHTS * ASMI ASMI.AS : Jefferies raises target price to EUR 880 from EUR 780 * B.P. Marsh & Partners Plc BPM.L : Jefferies raises target price to 625p from 560p * EasyJet EZJ.L : JP Morgan cuts target price to 640p from 670p * Kooth Plc KOO.L : Berenberg initiates coverage with buy rating;
3
A
A
A
A
B
B
C
C
C
D
D
E
E
E
F
K
A
H
A
A
D

UK Stocks-Factors to watch on June 26

UPDATE 1-UK Stocks-Factors to watch on June 26 Adds news items, updates futures June 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Wednesday, with futures FFIc1 up 0.37%. * ASTRAZENECA: China has approved the use of AstraZeneca's blockbuster cancer drug Tagrisso in combination with chemotherapy as a first line of treatment for adults with a type of advanced lung cancer, the company said on Wednesday.
A
D

Drax to sell 90,000 Opus customer meter points to EDF Energy Customers

Drax to sell 90,000 Opus customer meter points to EDF Energy Customers June 26 (Reuters) - Drax Group DRX.L , the UK's largest source of renewable electricity, said on Wednesday it has agreed to sell up to 90,000 small- and medium-sized (SME) customer meter points from its supply business Opus Energy to EDF Energy Customers Ltd. The asset sale for the majority of the Opus customer meter points follows the completion of a strategic review of the Drax's non-core SME energy supply business, the Lon
D

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.